{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:27:59Z","timestamp":1794252479268,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18735-y","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:38:49Z","timestamp":1759160329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones"],"prefix":"10.1038","volume":"15","author":[{"given":"Hina","family":"Aftab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyma","family":"Ate\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahri","family":"Akba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah K.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiqa","family":"Noreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"18735_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1353\/pbm.2019.0046","volume":"62","author":"DM Hausman","year":"2019","unstructured":"Hausman, D. M. What is cancer? Perspect. Biol. Med. 62, 778\u2013784. https:\/\/doi.org\/10.1353\/pbm.2019.0046 (2019).","journal-title":"Perspect. Biol. Med."},{"key":"18735_CR2","doi-asserted-by":"publisher","first-page":"115937","DOI":"10.1016\/j.jpba.2023.115937","volume":"240","author":"Y Lou","year":"2024","unstructured":"Lou, Y. et al. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS\/MS and its application in the clinical determination in patients with tumors associated with overactive bladder. J. Pharm. Biomed. Anal. 240, 115937. https:\/\/doi.org\/10.1016\/j.jpba.2023.115937 (2024).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"18735_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/TIM.2025.3563000","volume":"PP","author":"R Liu","year":"2025","unstructured":"Liu, R., Wang, S., Tian, F. & Yi, L. SIR-3DCNN: A framework of multivariate time series classification for lung cancer detection. IEEE Trans. Instrum. Meas. PP, 1\u20131. https:\/\/doi.org\/10.1109\/TIM.2025.3563000 (2025).","journal-title":"IEEE Trans. Instrum. Meas."},{"key":"18735_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"18735_CR5","doi-asserted-by":"publisher","unstructured":"Kratzer, T. B. et al. Lung cancer statistics, CANCER 130, 1330\u20131348, (2023). https:\/\/doi.org\/10.1002\/cncr.35128 (2024).","DOI":"10.1002\/cncr.35128"},{"key":"18735_CR6","doi-asserted-by":"publisher","first-page":"e70045","DOI":"10.1002\/pon.70045","volume":"33","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Effects of Web-Based acceptance and commitment therapy on Health-Related outcomes among patients with lung cancer: A feasibility randomized controlled trial. Psycho-Oncology 33, e70045. https:\/\/doi.org\/10.1002\/pon.70045 (2024).","journal-title":"Psycho-Oncology"},{"key":"18735_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cancergen.2024.04.001","volume":"284\u2013285","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer. Cancer Genet. 284\u2013285, 34\u201342. https:\/\/doi.org\/10.1016\/j.cancergen.2024.04.001 (2024).","journal-title":"Cancer Genet."},{"key":"18735_CR8","doi-asserted-by":"publisher","first-page":"140937","DOI":"10.1016\/j.molstruc.2024.140937","volume":"1325","author":"A K\u00f6se","year":"2025","unstructured":"K\u00f6se, A., K\u00f6se, L. P., \u015eenol, H. & Ulusoy-G\u00fczeldemirci, N. New 4-methanesulfonyloxy benzohydrazide derivatives as potential antioxidant and carbonic anhydrase I and II inhibitors: synthesis, characterization, molecular docking, dynamics & ADME studies. J. Mol. Struct. 1325, 140937. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140937 (2025).","journal-title":"J. Mol. Struct."},{"key":"18735_CR9","doi-asserted-by":"publisher","unstructured":"Polat K\u00f6se, L. & K\u00f6se, A. Identification of hCA I, hCA II, AChE and BChE Inhibitory Properties of Some Norcantharimide Derivatives; Molecular Docking, SAR and in silico ADME Studies. ChemistrySelect 9, e202400684, (2024). https:\/\/doi.org\/10.1002\/slct.202400684","DOI":"10.1002\/slct.202400684"},{"key":"18735_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/10426507.2024.2320672","volume":"199","author":"ED Dincel","year":"2024","unstructured":"Dincel, E. D. et al. Synthesis and in vitro carbonic anhydrase and acetylcholinesterase inhibitory activities of novel hydrazide\u2013hydrazone compounds containing 1,2,4-triazole ring. Phosphorus Sulfur Silicon Relat. Elem. 199, 236\u2013244. https:\/\/doi.org\/10.1080\/10426507.2024.2320672 (2024).","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"18735_CR11","doi-asserted-by":"publisher","unstructured":"Tokal\u0131, F. S., Taslimi, P., Sadeghi, M. & \u015eenol, H. Synthesis and Evaluation of Quinazolin-4(3)-one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry-Oriented Drug Design. ChemistrySelect 8, e202301158, (2023). https:\/\/doi.org\/10.1002\/slct.202301158","DOI":"10.1002\/slct.202301158"},{"key":"18735_CR12","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.21037\/tlcr-24-811","volume":"13","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Fluorofenidone enhances cisplatin efficacy in non-small cell lung cancer: a novel approach to inhibiting cancer progression. Transl Lung Cancer Res. 13, 3175\u20133188. https:\/\/doi.org\/10.21037\/tlcr-24-811 (2024).","journal-title":"Transl Lung Cancer Res."},{"key":"18735_CR13","doi-asserted-by":"publisher","first-page":"1507677","DOI":"10.3389\/fonc.2025.1507677","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang, J., Dong, X., Liu, Y., Lin, K. & Chen, J. Copy number gain of MET gene with low level in a metastatic lung adenocarcinoma patient represents response to salvage treatment with Savolitinib and osimertinib: a case report. Front. Oncol. 15, 1507677. https:\/\/doi.org\/10.3389\/fonc.2025.1507677 (2025).","journal-title":"Front. Oncol."},{"key":"18735_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5530\/ijper.53.2.35","volume":"53","author":"S \u00d6kten","year":"2019","unstructured":"\u00d6kten, S. et al. SAR evaluation of disubstituted Tacrine analogues as promising cholinesterase and carbonic anhydrase inhibitors. Indian J. Pharm. Educ. Res. 53, 268\u2013275. https:\/\/doi.org\/10.5530\/ijper.53.2.35 (2019).","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"18735_CR15","doi-asserted-by":"publisher","first-page":"111702","DOI":"10.1016\/j.ejmech.2019.111702","volume":"183","author":"B Zengin Kurt","year":"2019","unstructured":"Zengin Kurt, B. et al. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular Docking studies. Eur. J. Med. Chem. 183, 111702. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111702 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"18735_CR16","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.2147\/dddt.S490930","volume":"18","author":"MM Al-Sanea","year":"2024","unstructured":"Al-Sanea, M. M. et al. Synthesis, Pharmacological evaluation of Quinazolin-4(3H)-Ones bearing Urea functionality as potential VEGFR-2 inhibitors. Drug Des. Devel Ther. 18, 5109\u20135127. https:\/\/doi.org\/10.2147\/dddt.S490930 (2024). Design.","journal-title":"Drug Des. Devel Ther."},{"key":"18735_CR17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.22038\/ijbms.2024.74820.16246","volume":"27","author":"MT Liu","year":"2024","unstructured":"Liu, M. T. & Li, H. Apatinib has anti-tumor effects and induces autophagy in lung cancer cells with high expression of VEGFR-2. Iran. J. Basic. Med. Sci. 27, 1370\u20131379. https:\/\/doi.org\/10.22038\/ijbms.2024.74820.16246 (2024).","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"18735_CR18","doi-asserted-by":"publisher","unstructured":"Szczepanski, J. et al. Rhodanine-Piperazine hybrids as potential VEGFR, EGFR, and HER2 targeting Anti-Breast cancer agents. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms252212401 (2024).","DOI":"10.3390\/ijms252212401"},{"key":"18735_CR19","doi-asserted-by":"publisher","unstructured":"Swalduz, A. et al. Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): results from the IFCT-2004 blade cohort. Lung Cancer. 199 https:\/\/doi.org\/10.1016\/j.lungcan.2024.108038 (2025).","DOI":"10.1016\/j.lungcan.2024.108038"},{"key":"18735_CR20","doi-asserted-by":"publisher","unstructured":"Di Federico, A. et al. Clinical and preclinical activity of EGFR tyrosine kinase inhibitors in Non-Small-Cell lung cancer harboring\u2009<\u2009i\u2009>\u2009braf class 3 mutations. Jco Precision Oncol. 8 https:\/\/doi.org\/10.1200\/PO.24.00240 (2024).","DOI":"10.1200\/PO.24.00240"},{"key":"18735_CR21","doi-asserted-by":"publisher","first-page":"139519","DOI":"10.1016\/j.molstruc.2024.139519","volume":"1319","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Ate\u015fo\u011flu, \u015e., Tokal\u0131, P. & Akba\u015f, F. Exploring highly selective polymethoxy Fenamate isosteres as novel anti-prostate cancer agents: synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies. J. Mol. Struct. 1319, 139519. https:\/\/doi.org\/10.1016\/j.molstruc.2024.139519 (2025).","journal-title":"J. Mol. Struct."},{"key":"18735_CR22","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1021\/acs.jmedchem.3c01115","volume":"67","author":"B Zengin Kurt","year":"2024","unstructured":"Zengin Kurt, B. et al. Synthesis of Sorafenib\u2009\u2013\u2009Ruthenium complexes, investigation of biological activities and applications in drug delivery systems as an anticancer agent. J. Med. Chem. 67, 4463\u20134482. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01115 (2024).","journal-title":"J. Med. Chem."},{"key":"18735_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/cbr.2015.1921","volume":"31","author":"X Lin","year":"2016","unstructured":"Lin, X. et al. Regulation of oncoprotein 18\/stathmin signaling by ERK concerns the resistance to taxol in nonsmall cell lung cancer cells. Cancer Biother Radiopharm. 31, 37\u201343. https:\/\/doi.org\/10.1089\/cbr.2015.1921 (2016).","journal-title":"Cancer Biother Radiopharm"},{"key":"18735_CR24","doi-asserted-by":"publisher","first-page":"22645","DOI":"10.1038\/s41598-024-72858-2","volume":"14","author":"H Aftab","year":"2024","unstructured":"Aftab, H. et al. Design, synthesis, in vitro and in Silico studies of novel piperidine derived thiosemicarbazones as inhibitors of dihydrofolate reductase. Sci. Rep. 14, 22645 (2024).","journal-title":"Sci. Rep."},{"key":"18735_CR25","doi-asserted-by":"publisher","unstructured":"Danisman-Kalindemirtas, F. et al. Enhanced anticancer effect of newly synthesised albumin-bound Fe(III)-S-Methyl-thiosemicarbazones on breast cancer cells. J. Taibah Univ. Sci. 18 https:\/\/doi.org\/10.1080\/16583655.2024.2375454 (2024).","DOI":"10.1080\/16583655.2024.2375454"},{"key":"18735_CR26","doi-asserted-by":"publisher","unstructured":"Ibrahim, A. B. M., Mayer, P. & Abbas, S. M. Thiosemicarbazones and derived Tin complexes: synthesis, structural analysis and in vitro evaluation against bacterial and cancer cells. Appl. Organomet. Chem. 38 https:\/\/doi.org\/10.1002\/aoc.7620 (2024).","DOI":"10.1002\/aoc.7620"},{"key":"18735_CR27","doi-asserted-by":"publisher","unstructured":"Mohammed, M. O., Alkubaisi, H. M. M., Haj, N. Q. & Synthesis Identification, and anti-cancer evaluation of some heterocyclic Chitosan-Thiosemicarbazones compounds and their nickle (II) complexes. Res. Chem. 12 https:\/\/doi.org\/10.1016\/j.rechem.2024.101859 (2024).","DOI":"10.1016\/j.rechem.2024.101859"},{"key":"18735_CR28","doi-asserted-by":"publisher","DOI":"10.21577\/0103-5053.20230128","author":"DDS Oliveira","year":"2023","unstructured":"Oliveira, D. D. S. et al. Advances in breast cancer drug discovery: A review of therapeutic strategies and studies involving photosensitizers, caged Xanthones and thiosemicarbazones derivatives. J. Braz. Chem. Soc. https:\/\/doi.org\/10.21577\/0103-5053.20230128 (2023).","journal-title":"J. Braz. Chem. Soc."},{"key":"18735_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/00958972.2012.757762","volume":"66","author":"JG Da Silva","year":"2013","unstructured":"Da Silva, J. G., Perdig\u00c3O, C. C. H., Speziali, N. L. & Beraldo, H. Chalcone-derived thiosemicarbazones and their zinc(II) and gallium(III) complexes: spectral studies and antimicrobial activity. J. Coord. Chem. 66, 385\u2013401. https:\/\/doi.org\/10.1080\/00958972.2012.757762 (2013).","journal-title":"J. Coord. Chem."},{"key":"18735_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ardp.201300057","volume":"346","author":"A Saeed","year":"2013","unstructured":"Saeed, A., Al-Masoudi, N. A. & Latif, M. Synthesis and antiviral activity of new substituted Methyl [2-(arylmethylene-hydrazino)-4-oxo-thiazolidin-5-ylidene]acetates. Arch. Pharm. (Weinheim). 346, 618\u2013625. https:\/\/doi.org\/10.1002\/ardp.201300057 (2013).","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"18735_CR31","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1016\/j.bmc.2017.05.056","volume":"25","author":"MCS Santacruz","year":"2017","unstructured":"Santacruz, M. C. S., Fabiani, M., Castro, E. F., Cavallaro, L. V. & Finkielsztein, L. M. Synthesis, antiviral evaluation and molecular Docking studies of N4 Aryl substituted\/unsubstituted thiosemicarbazones derived from 1-indanones as potent anti-bovine viral diarrhea virus agents. Bioorg. Med. Chem. Lett. 25, 4055\u20134063. https:\/\/doi.org\/10.1016\/j.bmc.2017.05.056 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"18735_CR32","doi-asserted-by":"publisher","first-page":"140197","DOI":"10.1016\/j.molstruc.2024.140197","volume":"1321","author":"A Farzaliyeva","year":"2025","unstructured":"Farzaliyeva, A. et al. Synthesis and biological studies of acetophenone-based novel chalcone, semicarbazone, thiosemicarbazone and Indolone derivatives: Structure-Activity relationship, molecular docking, molecular dynamics, and kinetic studies. J. Mol. Struct. 1321, 140197. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140197 (2025).","journal-title":"J. Mol. Struct."},{"key":"18735_CR33","doi-asserted-by":"publisher","unstructured":"Uytun, A. N. et al. Synthesis of novel thiosemicarbazone derivatives and investigation of their dual ache and MAO-B inhibitor effects. J. Mol. Recognit. 35 https:\/\/doi.org\/10.1002\/jmr.2990 (2022).","DOI":"10.1002\/jmr.2990"},{"key":"18735_CR34","doi-asserted-by":"publisher","unstructured":"Abdelbaki, H. et al. Synthesis of bioactive 1,4-disubstituted 1,2,3-triazole-linked thiosemicarbazone derivatives using Cu2O microbeads catalysis for enhanced antibacterial and antioxidant activities. J. Mol. Struct. 1324 https:\/\/doi.org\/10.1016\/j.molstruc.2024.140784 (2025).","DOI":"10.1016\/j.molstruc.2024.140784"},{"key":"18735_CR35","doi-asserted-by":"publisher","unstructured":"Azimi, F. et al. Kinetic studies, molecular docking, and antioxidant activity of novel 1,3-diphenyl pyrazole-thiosemicarbazone with anti-tyrosinase and anti-melanogenesis properties. Bioorg. Chem. 152 https:\/\/doi.org\/10.1016\/j.bioorg.2024.107722 (2024).","DOI":"10.1016\/j.bioorg.2024.107722"},{"key":"18735_CR36","doi-asserted-by":"publisher","unstructured":"Sousa, G. L. S. et al. Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of Alzheimer\u2019s disease: In vitro, in vivo, and in silico studies. Eur. J. Med. Chem. 281 https:\/\/doi.org\/10.1016\/j.ejmech.2024.117030 (2025).","DOI":"10.1016\/j.ejmech.2024.117030"},{"key":"18735_CR37","doi-asserted-by":"publisher","unstructured":"\u00c7elik, E. et al. DNA and hemoglobin binding activities: investigation of coumarin-thiosemicarbazone hybrids. Bioorg. Chem. 153 https:\/\/doi.org\/10.1016\/j.bioorg.2024.107857 (2024).","DOI":"10.1016\/j.bioorg.2024.107857"},{"key":"18735_CR38","doi-asserted-by":"publisher","unstructured":"Jacob, J. M. et al. Multi-faceted investigation of copper(II) chelates based on ONS donor thiosemicarbazone: crystal structures, spectral aspects, DNA binding, cytotoxicity and computational studies. J. Mol. Struct. 1319 https:\/\/doi.org\/10.1016\/j.molstruc.2024.139463 (2025).","DOI":"10.1016\/j.molstruc.2024.139463"},{"key":"18735_CR39","doi-asserted-by":"publisher","unstructured":"Nicol\u00e1s, A., Quero, J. G., Barroso, M., Gandara, Z. & Gude, L. D. N. A. Interactions and Biological Activity of 2,9-Disubstituted 1,10-Phenanthroline Thiosemicarbazone-Based Ligands and a 4-Phenylthiazole Derivative. Biology-Basel 13, (2024). https:\/\/doi.org\/10.3390\/biology13010060","DOI":"10.3390\/biology13010060"},{"key":"18735_CR40","doi-asserted-by":"crossref","unstructured":"Finch, R. A., Liu, M. C., Cory, A. H., Cory, J. G. & Sartorelli, A. C. in Advances in Enzyme Regulation Vol. 39 (ed G. Weber) Ch. 39th International Symposium on Regulation of Enzyme Activity and Synthesis in Normal and Neoplastic Tissues, 3\u201312 (1999).","DOI":"10.1016\/S0065-2571(98)00017-X"},{"key":"18735_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/109158100224890","volume":"19","author":"KC Lee","year":"2000","unstructured":"Lee, K. C., Noveroske, J. W. & Almassian, B. Short-term toxicological evaluation of triapine (3-amino-pyridine-2-carboxaldehyde thiosemicarbazone or 3-AP), a ribonucleotide reductase inhibitor with potential antitumor activity, in dogs and rats. Int. J. Toxicol. 19, 85\u201393. https:\/\/doi.org\/10.1080\/109158100224890 (2000).","journal-title":"Int. J. Toxicol."},{"key":"18735_CR42","doi-asserted-by":"publisher","unstructured":"Dharmasivam, M. et al. The thiosemicarbazone, dpc, broadly synergizes with multiple anti-cancer therapeutics and demonstrates temperature- and energy-dependent uptake by tumor cells. Biochim. Et Biophys. Acta-General Subj. 1866 https:\/\/doi.org\/10.1016\/j.bbagen.2022.130152 (2022).","DOI":"10.1016\/j.bbagen.2022.130152"},{"key":"18735_CR43","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00216-012-6562-x","volume":"405","author":"J Stariat","year":"2013","unstructured":"Stariat, J. et al. Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, dpc, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. Anal. Bioanal. Chem. 405, 1651\u20131661. https:\/\/doi.org\/10.1007\/s00216-012-6562-x (2013).","journal-title":"Anal. Bioanal. Chem."},{"key":"18735_CR44","doi-asserted-by":"publisher","unstructured":"Doumi, I., Lang, L., Vileno, B., Deponte, M. & Faller, P. Glutathione protects other cellular thiols against oxidation by Cu\u2009<\u2009SUP\u2009>\u2009II-Dp44mT. Chemistry-A Eur. J. 30 https:\/\/doi.org\/10.1002\/chem.202304212 (2024).","DOI":"10.1002\/chem.202304212"},{"key":"18735_CR45","doi-asserted-by":"publisher","unstructured":"Ismail, M. et al. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth Inhibition. Biomaterials 289 https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121760 (2022).","DOI":"10.1016\/j.biomaterials.2022.121760"},{"key":"18735_CR46","doi-asserted-by":"publisher","unstructured":"Krishan, S., Sahni, S. & Richardson, D. R. The anti-tumor agent, Dp44mT, promotes nuclear translocation of tfeb\u2009<\u2009i\u2009>\u2009via inhibition of the AMPK-mTORC1 axis. Biochim. Et Biophys. Acta-Molecular Basis Disease. 1866 https:\/\/doi.org\/10.1016\/j.bbadis.2020.165970 (2020).","DOI":"10.1016\/j.bbadis.2020.165970"},{"key":"18735_CR47","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bioorg.2018.11.033","volume":"84","author":"AA Abdel-Aziz","year":"2019","unstructured":"Abdel-Aziz, A. A. et al. Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: dual cyclooxygenase\/carbonic anhydrase inhibitory actions. Bioorg. Chem. 84, 260\u2013268. https:\/\/doi.org\/10.1016\/j.bioorg.2018.11.033 (2019).","journal-title":"Bioorg. Chem."},{"key":"18735_CR48","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1080\/07391102.2020.1792345","volume":"39","author":"HU Celebioglu","year":"2021","unstructured":"Celebioglu, H. U. et al. Cytotoxic effects, carbonic anhydrase isoenzymes, alpha-glycosidase and acetylcholinesterase inhibitory properties, and molecular Docking studies of heteroatom-containing sulfonyl hydrazone derivatives. J. Biomol. Struct. Dyn. 39, 5539\u20135550. https:\/\/doi.org\/10.1080\/07391102.2020.1792345 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"18735_CR49","doi-asserted-by":"publisher","first-page":"108118","DOI":"10.1016\/j.bioorg.2024.108118","volume":"155","author":"J Eshal","year":"2025","unstructured":"Eshal, J. et al. Synthesis, biological evaluation, and in Silico studies of phenyl naphthalene-2-sulfonate derived thiosemicarbazones as potential carbonic anhydrase inhibitors. Bioorg. Chem. 155, 108118. https:\/\/doi.org\/10.1016\/j.bioorg.2024.108118 (2025).","journal-title":"Bioorg. Chem."},{"key":"18735_CR50","doi-asserted-by":"publisher","first-page":"e202300407","DOI":"10.1002\/elan.202300407","volume":"36","author":"OC Altunoluk","year":"2024","unstructured":"Altunoluk, O. C., \u00d6zbek, O., Kalay, E., Tokal\u0131, F. S. & Aslan, O. N. Surface characterization of barium(II)-selective potentiometric sensor based on a newly synthesized thiosemicarbazone derivative molecule. Electroanalysis 36, e202300407. https:\/\/doi.org\/10.1002\/elan.202300407 (2024).","journal-title":"Electroanalysis"},{"key":"18735_CR51","doi-asserted-by":"publisher","first-page":"e202204191","DOI":"10.1002\/slct.202204191","volume":"8","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., Al\u0131m, Z. & Y\u0131rt\u0131c\u0131, \u00dc. Carboxylate- and Sulfonate-Containing Quinazolin-4(3H)-one rings: synthesis, characterization, and carbonic anhydrase I\u2013II and acetylcholinesterase Inhibition properties. ChemistrySelect 8, e202204191. https:\/\/doi.org\/10.1002\/slct.202204191 (2023).","journal-title":"ChemistrySelect"},{"key":"18735_CR52","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s13738-023-02861-3","volume":"20","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S. et al. Synthesis of new carboxylates and sulfonates containing thiazolidin-4-one ring and evaluation of inhibitory properties against some metabolic enzymes. J. Iran. Chem. Soc. 20, 2631\u20132642. https:\/\/doi.org\/10.1007\/s13738-023-02861-3 (2023).","journal-title":"J. Iran. Chem. Soc."},{"key":"18735_CR53","doi-asserted-by":"publisher","first-page":"26241","DOI":"10.1039\/d1ra05277b","volume":"11","author":"MTM Nemr","year":"2021","unstructured":"Nemr, M. T. M. et al. Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents carbonic anhydrase IX Inhibition. Rsc Adv. 11, 26241\u201326257. https:\/\/doi.org\/10.1039\/d1ra05277b (2021).","journal-title":"Rsc Adv."},{"key":"18735_CR54","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2174\/138161208783877893","volume":"14","author":"S Pastorekova","year":"2008","unstructured":"Pastorekova, S., Zatovicova, M. & Pastorek, J. Cancer-associated carbonic anhydrases and their Inhibition. Curr. Pharm. Des. 14, 685\u2013698. https:\/\/doi.org\/10.2174\/138161208783877893 (2008).","journal-title":"Curr. Pharm. Des."},{"key":"18735_CR55","doi-asserted-by":"publisher","first-page":"45842","DOI":"10.1021\/acsomega.4c04639","volume":"9","author":"M Moussaoui","year":"2024","unstructured":"Moussaoui, M. et al. Design and optimization of Quinazoline derivatives as potent EGFR inhibitors for lung cancer treatment: A comprehensive QSAR, ADMET, and molecular modeling investigation. ACS Omega. 9, 45842\u201345857. https:\/\/doi.org\/10.1021\/acsomega.4c04639 (2024).","journal-title":"ACS Omega"},{"key":"18735_CR56","doi-asserted-by":"publisher","first-page":"16418","DOI":"10.1038\/s41598-024-66877-2","volume":"14","author":"M Moussaoui","year":"2024","unstructured":"Moussaoui, M. et al. QSAR, ADMET, molecular docking, and dynamics studies of 1,2,4-triazine-3(2H)-one derivatives as tubulin inhibitors for breast cancer therapy. Sci. Rep. 14, 16418. https:\/\/doi.org\/10.1038\/s41598-024-66877-2 (2024).","journal-title":"Sci. Rep."},{"key":"18735_CR57","doi-asserted-by":"publisher","first-page":"134114","DOI":"10.1016\/j.molstruc.2022.134114","volume":"1271","author":"S Zareei","year":"2023","unstructured":"Zareei, S., Mohammadi-Khanaposhtani, M., Adib, M., Mahdavi, M. & Taslimi, P. Sulfonamide-phosphonate hybrids as new carbonic anhydrase inhibitors: in vitro enzymatic inhibition, molecular modeling, and ADMET prediction. J. Mol. Struct. 1271, 134114. https:\/\/doi.org\/10.1016\/j.molstruc.2022.134114 (2023).","journal-title":"J. Mol. Struct."},{"key":"18735_CR58","doi-asserted-by":"publisher","first-page":"31409","DOI":"10.1039\/D4RA05071A","volume":"14","author":"H Aftab","year":"2024","unstructured":"Aftab, H. et al. Synthesis, in vitro biological evaluation and in Silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors. RSC Adv. 14, 31409\u201331421 (2024).","journal-title":"RSC Adv."},{"key":"18735_CR59","doi-asserted-by":"crossref","unstructured":"Munir, I. et al. Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: In-vitro and in Silico approach. Bioorganic & Med. Chemistry, 118301 (2025).","DOI":"10.1016\/j.bmc.2025.118301"},{"key":"18735_CR60","doi-asserted-by":"publisher","first-page":"e2300423","DOI":"10.1002\/ardp.202300423","volume":"356","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Yetke, H. I. & Hac\u0131osmano\u011flu-Aldogan, E. Novel quinazoline-chromene hybrids as anticancer agents: synthesis, biological activity, molecular docking, dynamics and ADME studies. Arch. Pharm. 356, e2300423. https:\/\/doi.org\/10.1002\/ardp.202300423 (2023).","journal-title":"Arch. Pharm."},{"key":"18735_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.procbio.2023.11.029","volume":"136","author":"\u00d6 Demirk\u0131ran","year":"2024","unstructured":"Demirk\u0131ran, \u00d6. et al. Cytotoxic meroterpenoids from brown Alga Stypopodium schimperi (K\u00fctzing) verlaque & Boudouresque with comprehensive molecular Docking & dynamics and ADME studies. Process Biochem. 136, 90\u2013108. https:\/\/doi.org\/10.1016\/j.procbio.2023.11.029 (2024).","journal-title":"Process Biochem."},{"key":"18735_CR62","doi-asserted-by":"publisher","first-page":"138998","DOI":"10.1016\/j.molstruc.2024.138998","volume":"1315","author":"OV Petrova","year":"2024","unstructured":"Petrova, O. V. et al. Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: an in vitro-in Silico study. J. Mol. Struct. 1315, 138998. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138998 (2024).","journal-title":"J. Mol. Struct."},{"key":"18735_CR63","doi-asserted-by":"publisher","first-page":"136804","DOI":"10.1016\/j.molstruc.2023.136804","volume":"1295","author":"H \u015eenol","year":"2024","unstructured":"\u015eenol, H., Ghaffari-Moghaddam, M., Toraman, A., G\u00fcller, U. & G. \u00d6. & Novel chalcone derivatives of ursolic acid as acetylcholinesterase inhibitors: synthesis, characterization, biological activity, ADME prediction, molecular Docking and molecular dynamics studies. J. Mol. Struct. 1295, 136804. https:\/\/doi.org\/10.1016\/j.molstruc.2023.136804 (2024).","journal-title":"J. Mol. Struct."},{"key":"18735_CR64","doi-asserted-by":"publisher","first-page":"e202301089","DOI":"10.1002\/cbdv.202301089","volume":"20","author":"H \u015eenol","year":"2023","unstructured":"\u015eenol, H. et al. Synthesis and anticancer activity of novel derivatives of alpha,beta-Unsaturated ketones based on oleanolic acid: in vitro and in Silico studies against prostate cancer cells. Chem. Biodivers. 20, e202301089. https:\/\/doi.org\/10.1002\/cbdv.202301089 (2023).","journal-title":"Chem. Biodivers."},{"key":"18735_CR65","doi-asserted-by":"publisher","first-page":"996","DOI":"10.12688\/f1000research.52168.2","volume":"19","author":"N K\u0131l\u0131n\u00e7","year":"2022","unstructured":"K\u0131l\u0131n\u00e7, N., A\u00e7ar, M., Tuncay, S. & Karasakal, F. \u00d6. Potential inhibitors identification of severe acute respiratory syndrome-related coronavirus 2 (SARS-COV-2) angiotensin-converting enzyme 2 and main protease from Anatolian traditional plants. Lett. Drug Des. Discov. 19, 996\u20131006. https:\/\/doi.org\/10.12688\/f1000research.52168.2 (2022).","journal-title":"Lett. Drug Des. Discov"},{"key":"18735_CR66","doi-asserted-by":"publisher","first-page":"140702","DOI":"10.1016\/j.molstruc.2024.140702","volume":"1322","author":"F \u00c7ak\u0131r","year":"2025","unstructured":"\u00c7ak\u0131r, F. et al. Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: synthesis, characterization and in vitro & in Silico biological activity studies. J. Mol. Struct. 1322, 140702. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140702 (2025).","journal-title":"J. Mol. Struct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18735-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:38:51Z","timestamp":1759160331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18735-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18735"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18735-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33402"}}